TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.

Geoffrey J Lindeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.